Gene · 54894
Papers2,200
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,200
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical Validity of Tumor-Informed Circulating Tumor DNA Analysis in Patients Undergoing Surgery of Colorectal Metastases. | Dis Colon Rectum | 2023 | 35857852 | PubTator, text mining | PubMed |
| Wnt signaling in liver regeneration, disease, and cancer. | Clin Mol Hepatol | 2023 | 35785913 | PubTator, text mining | PubMed |
| Oncogenic fusion transcript analysis identified ADAP1-NOC4L, potentially associated with metastatic colorectal cancer. | Cancer Med | 2023 | 35702822 | PubTator, text mining | PubMed |
| DPEP1 promotes drug resistance in colon cancer cells by forming a positive feedback loop with ASCL2. | Cancer Med | 2023 | 35670012 | PubTator, text mining | PubMed |
| LSM12 facilitates the progression of colorectal cancer by activating the WNT/CTNNB1 signaling pathway. | Oncol Res | 2022 | 37303493 | PubTator, text mining | PubMed |
| Multiregional Sequencing Analysis Reveals Extensive Genetic Heterogeneity in Gastric Tumors from Latinos. | Cancer Res Commun | 2022 | 36970058 | PubTator, text mining | PubMed |
| The Wnt Pathway Inhibitor RXC004 Blocks Tumor Growth and Reverses Immune Evasion in Wnt Ligand-dependent Cancer Models. | Cancer Res Commun | 2022 | 36922934 | PubTator, text mining | PubMed |
| Whole genome sequencing of Malaysian colorectal cancer patients reveals specific druggable somatic mutations. | Front Mol Biosci | 2022 | 36866106 | PubTator, text mining | PubMed |
| Targeting BRAF V600E in metastatic colorectal cancer: where are we today? | Ecancermedicalscience | 2022 | 36819812 | PubTator, text mining | PubMed |
Comprehensive genomic profiling of upper tract urothelial carcinoma and urothelial carcinoma of the bladder identifies distinct molecular characterizations with potential implications for targeted therapy & immunotherapy. | Front Immunol | 2022 | 36818471 | PubTator, text mining | PubMed |
| A four oxidative stress gene prognostic model and integrated immunity-analysis in pancreatic adenocarcinoma. | Front Oncol | 2022 | 36713541 | PubTator, text mining | PubMed |
| High expression of RNF169 is associated with poor prognosis in pancreatic adenocarcinoma by regulating tumour immune infiltration. | Front Genet | 2022 | 36685833 | PubTator, text mining | PubMed |
| A study of gene variation in All-RAS wild-type metastatic colorectal cancer and its correlation with cetuximab. | J Gastrointest Oncol | 2022 | 36636055 | PubTator, text mining | PubMed |
| Clinical features and long-term outcomes of patients with colonic oligopolyposis of unknown etiology. | World J Gastroenterol | 2022 | 36632322 | PubTator, text mining | PubMed |
| A lncRNA-immune checkpoint-related gene signature predicts metastasis-free survival in prostate adenocarcinoma. | Transl Androl Urol | 2022 | 36632155 | PubTator, text mining | PubMed |
| Role of tumor-derived exosomes in metastasis, drug resistance and diagnosis of clear cell renal cell carcinoma. | Front Oncol | 2022 | 36620603 | PubTator, text mining | PubMed |
| Systematic Review and Meta-analysis of TP53, HER2/ERBB2, KRAS, APC, and PIK3CA Genes Expression Pattern in Gastric Cancer. | Middle East J Dig Dis | 2022 | 36619267 | PubTator, text mining | PubMed |
| A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer. | Int J Mol Sci | 2022 | 36613599 | PubTator, text mining | PubMed |
| A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy. | Int J Mol Sci | 2022 | 36613564 | PubTator, text mining | PubMed |
| Honeycomb-like Structured Film, a Novel Therapeutic Device, Suppresses Tumor Growth in an In Vivo Ovarian Cancer Model. | Cancers (Basel) | 2022 | 36612230 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54894/papers?page=26